Call Today for a FREE Confidential Case Review - Toll-Free 24/7 (866) 920-0753

Johnson & Johnson Risperdal Settlement

Johnson & Johnson Risperdal Settlement

Risperdal (risperidone) was illegally marketed to children with behavior problems between 1999-2005. Unfortunately, many children were injured by Risperdal side effects, including breast growth in males (gynecomastia), severe weight gain, type-2 diabetes, and more. Today, over $3 billion has been paid in Johnson & Johnson Risperdal settlements.

What You Can Do & How a Risperdal Lawsuit Can Help

The Schmidt Firm, PLLC is currently accepting Risperdal induced injury cases in all 50 states. If you or somebody you know was injured by Risperdal, you should contact our lawyers immediately for a free case consultation. Please use the form below to contact our Defective Drug Litigation Group or call us toll-free 24 hours a day at (866) 920-0753.

Johnson & Johnson Risperdal Settlement Awarded for $2.2 Billion

November 2013 — The U.S. Department of Justice (DOJ) and Johnson & Johnson (J&J) have agreed to a $2.2 billion settlement. The DOJ announced that the settlement will resolve civil and criminal allegations that the company engaged in illegal, “off-label” marketing of Risperdal in children, elderly dementia patients, and people with intellectual disabilities.

Prosecutors from the DOJ allege that J&J ignored multiple warnings from the FDA and studies linking Risperdal to gynecomastia (breast growth) and diabetes in children. Sales representatives were instructed to tell child psychiatrists that Risperdal was a safe treatment for common disorders, including ADHD, obsessive-compulsive disorder, and more. Risperdal was not approved for pediatric uses until 2006.

Five More Risperdal Breast Growth Lawsuits Before Trials Begin

October 2012 —Johnson & Johnson has agreed to settlements with four plaintiffs who were injured by gynecomastia from Risperdal. In addition to avoiding jury trials, FDA Commissioner David Kessler (a former pediatrician) will not be required to testify.

According to the Philadelphia Inquirer:

“J&J settled four so-called bellwether cases Thursday morning for undisclosed amounts. Asked if the prospect of Kessler testifying against the company prompted it to offer enough to settle, plaintiffs’ attorney Stephen Sheller said, “Yes.”

Risperdal Gynecomastia Lawsuit Settlement on 1st Day of Trial

September 2012 — Johnson & Johnson has agreed to an undisclosed settlement with a 21 year-old plaintiff, Aaron Banks, who developed severe gynecomastia after taking Risperdal from 1999 until 2004, starting when he was just 9 years old. Risperdal was not approved for children during this time. Mr. Banks allegedly suffered psychological trauma, physical disfigurement, and required surgery to correct his condition.

Mr. Banks’ attorney told Bloomberg News:

“This drug caused female breasts to grow on little boys around the country. Their childhoods were stolen, but billions were made.”

Johnson & Johnson Risperdal Healthcare Fraud Settlements for $2 Billion

The Risperdal litigation began in 2004 with a whistleblower lawsuit. The plaintiff, Allen Jones, was a former investigator for the Pennsylvania Office of the Inspector General. After investigating suspicious payments J&J made to a pharmacist in the Pennsylvania state government, he discovered evidence that J&J was using questionable safety studies and incentivizing health officials to recommend Risperdal over cheaper, equally-effective alternatives.

Based on this evidence, several states filed lawsuits alleging that J&J defrauded taxpayer-funded healthcare systems. J&J lost four consecutive lawsuits, totaling about $2 billion. These lawsuits included: South Carolina ($327 million), Louisiana ($257.7 million), Arkansas ($1.2 billion), and Texas ($158 million).

Johnson & Johnson Risperdal Settlement Information

The Schmidt Firm, PLLC is currently accepting Risperdal injury cases in all 50 states. If you or somebody you know was injured by Risperdal, you should contact our lawyers immediately for a free case consultation. Please use the form below to contact our Defective Drug Litigation Group or call us toll-free 24 hours a day at (866) 920-0753.

Attention Lawyers: We consider a referral from another law firm to be one of the greatest compliments. If your firm is interested in referring us a case or for us to send you a list of previous award judgments and/or average referral fees, please visit the Lawyer Referral section of our website.

Free Case Evaluation

The Schmidt Firm, PLLC has been recognized as one of the nation’s leading plaintiffs’ law firms and handles cases in all 50 states. We are very proud of our legal achievements, but equally self-respecting of our firm’s reputation for providing personal attention to each and every client we represent.

No matter what type of case you have, you may contact us with confidence by filling out the email contact form below or calling us directly by dialing toll free 24 hrs/day (866) 920-0753.

*
*
*